What's new

Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 25, Status: Authorised

Feb 14, 2025 - 16:58
 0
Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 25, Status: Authorised
Read More

Tags:

Previous Article

Opinion/decision on a Paediatric investigation plan (PIP): Enerzair Breezhaler, ...

Next Article

EMEA-003467-PIP01-23

Related Posts

Careers

Careers

Feb 9, 2025  0

Veterinary medicines European public assessment report (EPAR): Omeprazole TriviumVet, omeprazole, Drugs for acid related disorders, Status: Opinion

Veterinary medicines European public assessment report ...

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Date of authorisation: 15/07/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 11, 2025  0